We have collected the world’s top experts in venous thromboembolism to present at VTE Dublin 2015. The programme is designed to cover all the relevant medical disciplines and to reflect contemporary management of VTE.

  • Programme [PDF Direct Download. Either click or right click and “save as”]

Speaker biographies [more to come]:

Alexander T Cohen

Alexander T Cohen
Alexander T Cohen

Consultant Vascular Physician and Epidemiologist, Department of Haematological Medicine, Guy’s and St Thomas’ Hospital, King’s College, London, UK.

Dr Cohen is a vascular physician and epidemiologist involved in clinical work, designing, managing, and analysing clinical trials from phase I to IV. He is the Chairman and member of many international steering committees for multicentre trials, epidemiological and pharmaco-economic studies. Dr Cohen graduated with honours in Medicine and honours in Surgery from the University of Melbourne, Australia (MBBS). He achieved his fellow of the Royal Australasian College of Physicians (FRACP) in 1990, and was awarded an MSc in Epidemiology in 1991 at the London School of Hygiene and Tropical Medicine, University of London. His MSc thesis in 1991 was on the Metabolic Syndrome in South Asian populations. In 1998, he achieved MD with a thesis on Epidemiology of VTE and Thromboprophylaxis. He was previously Director of Clinical Research and Epidemiologist in Thrombosis Research at King’s CollegeHospital, London He has written or co-authored over 350 publications since 1990. He has over 40 publications in the Lancet and New England Journal of Medicine (14 in the Lancet and 27 in NEJM, 10 in the last 3 years), as well as 17 in the British Medical Journal, Blood, Circulation, Annals of Internal Medicine and Archives of Internal Medicine.

Speaking on:

  • VTE Prophylaxis: Theory and Practice
    • Friday 18th September, 10.25


John Higgins

John Higgins
Professor John Higgins


UCC Professor of Obstetrics and Gynaecology and a practising consultant based at Cork University Maternity Hospital.  He is also the Head of the College of Medicine and Health at UCC.

He graduated from the medical school of Trinity College Dublin in 1988.  He trained initially in Internal Medicine (MRCPI 1991).  He commenced clinical and academic training in Obstetrics & Gynaecology at the Rotunda Hospital and the TCD Department of Obstetrics & Gynaecology (MRCOG 1996, MD 1996).

He then undertook a fellowship at the University of Melbourne, Perinatal Research Centre at the Royal Women’s Hospital, Melbourne.  He was appointed Senior Lecturer at the University of Melbourne and Consultant Obstetrician & Gynaecologist in the Mercy Hospital for Women in 2000.  His ongoing clinical and research interests remain in the areas he explored during this period – High Risk Pregnancy, Thrombophilia, and Haemostatic disturbances in pregnancy.  He was awarded the Blair-Bell Lectureship 1999 by the Royal College of Obstetricians & Gynaecologists and the Ella MacKnight Memorial Lectureship 2000 by the Royal Australian & New Zealand College of Obstetricians & Gynaecologists

He returned to Ireland to take up the UCC Chair in Obstetrics & Gynaecology in 2001.  At the same time, he took on the clinical leadership of the Maternity Services in Cork; a post he held until 2009 when he took up the post of Director of Reconfiguration of Acute Hospital Services in Cork & Kerry.  John has deep interest in organisational reform and change management.  He gained unique experience from leading the amalgamation of three maternity hospitals to form the new state-of-the art Cork University Maternity Hospital (CUMH).  Working closing with his colleagues, he has overseen the significant expansion of the Department of Obstetrics & Gynaecology and the development of the Anu Research Centre at CUMH.  He is strongly committed to the integration of the delivery of clinical care with the teaching, training, research and innovation agendas.  In April 2011 he was appointed Head of the College of Medicine and Health in University College Cork.

In June 2012, John was appointed Chair of the Strategic Board for Hospital Groups to advise the Minister for Health on reconfiguration of the Irish hospital system.


David Jiménez

David Jiménez

Associate Clinical Professor of Medicine, Medicine Department, Alcalá de Henares University.

Dr Jiménez is a world renowned writer and researcher in venous thromboembolism and has published several hundred peer reviewed papers on the subject.

Speaking on:

  • Outpatient Management of Low Risk PE: An International Perspective
    • Saturday 19th September, 0830



Pieter Willem Kamphuisen

Pieter Kamphuisen
Pieter Willem Kamphuisen


Professor of Medicine Department of Vascular Medicine University Medical Center Groningen Groningen, The Netherlands.

Pieter Willem Kamphuisen graduated in medicine at the University of Leiden in 1994. He did a PhD on the relationship between high levels of factor VIII and the risk of thrombosis, and defended his thesis in 2000. He completed his training in internal medicine and vascular medicine at the Radboud University Medical Center Nijmegen in 2004. From 2004-2005 he was a research fellow at the department of Vascular Medicine and Stroke Unit in Perugia, Italy. From 2006 until 2011 he was a staff member of the department of Vascular Medicine at the Academic Medical Center in Amsterdam. In 2009, Pieter Kamphuisen was a research fellow at the department of Cardiology in Birmingham, UK. He currently works at the department of Vascular Medicine at the University Medical Center Groningen.

He was appointed as professor of Vascular Medicine in December 2012. He is chair of the department of Vascular Medicine and the vascular lab at the UMCG, and leads the fellowship of Vascular Medicine for residents in internal medicine.

In his clinical work, Pieter Kamphuisen diagnoses and treats patients with a variety of vascular disorders and risk factors, such as venous thromboembolism, hypertension, dyslipidemia, vasculitis, and premature atherosclerosis, and complications of its treatment.

Furthermore, after completing a three year training in professional communication, he is involved in academic leadership training for MDs.

His scientific work addresses several fields of venous and arterial thrombosis, such as cancer & thrombosis, diagnosis of VTE, (reversal of) NOACs, and the role of coagulation in atrial fibrillation and atherosclerosis.

Pieter Kamphuisen is married and has three children.

Speaking on:

  • Short and Long-term outcome of VTE
    • Friday 18th September, 1050
  • Upper Limb DVT
    • Friday 18th September, 1725
  • Investigation of unprovoked DVT: Is there a role for Malignancy Screening?
    • Saturday 19th September, 1235


Saskia Middeldorp
Saskia Middeldorp

Saskia Middeldorp

Professor of Medicine, Department of Vascular Medicine Academic Medical Center Amsterdam The Netherlands

Saskia Middeldorp qualified as a medical doctor at the University of Amsterdam in 1992. She received her training in internal medicine at the Academic Medical Center in Amsterdam and obtained her board licence in 1999 (subspecialty Vascular Medicine, 2002). Since December 2010, she is professor and co-chair of the Department of Vascular Medicine of the Academic Medical Center. She leads the residency program of vascular medicine and the clinical thrombosis and haemostasis research lines of the Department. Her present research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and haemostasis, and the clinical evaluation of new anticoagulants.

Saskia Middeldorp defended her thesis entitled “Clinical and laboratory studies in hereditary and acquired prothrombotic states” in 2000. She was Associate Professor of the Department of Vascular Medicine in the Academic Medical Center (until December 2006) and co-director of the Dutch Cochrane Centre (2003-2005). From December 2006 to July 2010, she was Associate Professor in the Departments of Clinical Epidemiology and Internal Medicine at the Leiden University Medical Center.

Currently, Saskia Middeldorp holds a VIDI grant from the Netherlands Organisation for Scientific Research (NWO) on the topic “Thrombophilia and Reproduction” (2012-present). She is co-chair of the Scientific Subcommittee of Women’s Issues in Thrombosis and Haemostasis of the International Society of Thrombosis and Haemostasis (ISTH) and member of the ISTH Governance Committee (2013-present). Since 2014, she is president of the Netherlands Society on Thrombosis and Haemostasis (NVTH). She is member of the Venous Thrombosis Guideline Coordination Panel of the American Society of Hematology (ASH) (2014-present). Saskia Middeldorp co-authored the Pregnancy chapter of the 9th Edition Antithrombotic Guidelines of the American College of Chest Physicians (ACCP) in 2012.

She held a research fellowship (2003-2007) and was Clinical Established Investigator (2008-2010) of the Netherlands Heart Foundation. She was a member of the Advisory Board of The Journal of Thrombosis and Haemostasis (2001), is Editor of The Cochrane Collaborative Review Group on Peripheral Vascular Diseases (2003), Member of the Scientific Advisory Boards of the Netherlands Heart Foundation (2007-2010) and Dutch Thrombosis Foundation (2007-present). She also was member of advisory committees on new oral anticoagulants for the Health Council of the Netherlands and the Dutch Order of Medical Specialists. She has co-authored over 185 peer-reviewed papers and several book chapters, and reviews manuscripts for international scientific journals.

Speaking on:

  • VTE in Pregnancy
    • Friday 18th September, 1700


walter ageno
Walter Ageno

Walter Ageno

Associate Professor of Medicine at the University of Insubria and Director of the Short-Stay Medical Unit and Thrombosis Center at the Ospedale di Circolo of Varese, Italy.

Dr. Ageno has authored and co-authored more than 330 articles indexed in MEDLINE, as well as several abstracts presented at national and international meetings and more than 10 book chapters in the fields of venous and arterial thrombosis. He is coordinating international trials on the management of unusual site thrombosis and has also been a member of the steering committee or the safety monitoring board in a number of studies on the prevention and treatment of venous thromboembolism.

Dr. Ageno is chairman elect of the Italian Society of Hemostasis and Thrombosis, chairman of the Scientific Subcommittee of Control of Anticoagulation of the International Society on Thrombosis and Haemostasis, and chairman elect of the Scientific Subcommittee board of the International Society on Thrombosis and Haemostasis. He is deputy editor for Thrombosis and Haemostasis, associate editor for the Journal of Thrombosis and Haemostasis and Internal and Emergency Medicine and member of the Advisory Board of Vascular Medicine. He has contributed to a number of national and international guidelines on venous and arterial thrombosis.

Speaking on:

  • Splanchnic Vein Thrombosis/Cerebral Vein Thrombosis
    • Friday 18th September, 1635
  • Epidemiology; Mechanisms; Management
    • Saturday 19th September, 1150


John Stinson

John Stinson
John Stinson

John Stinson qualified in Medicine from Trinity College Dublin in 1985. He trained in Internal Medicine & Diabetes obtaining MRCPI and MD by thesis before his interest in clinical trials led him into Clinical Pharmacology & Therapeutics with the late Prof John Feely in Dublin and then to Liverpool University with Prof Sir Alistair Breckenridge. He became a Clinical Research Physician with Astra Zeneca in 1993 in phase I trials, and returned to Dublin with LEO Pharma as Medical Director in 1995. He obtained FRCPI in 1997 and FFPM RCP (UK) in 2001. Though still based in Ireland, he now is employed by LEO Pharma HQ, Denmark, working in Clinical Development & Safety Department as Medical Science Director mainly in the therapeutic area of Thrombosis. He maintains a small clinical commitment to St James Hospital and is a part-time/Adjunct Assistant Professor in the Department of Clinical Pharmacology in Trinity College, Dublin.

Speaking on:

  • Update on CATCH clinical trial
    • Saturday 19th September, 1300
Prof Harry Buller

Harry Buller

Harry R. Büller, MD, is Professor of Internal Medicine, specialized in Vascular Medicine at the Academic Medical Center in Amsterdam, The Netherlands.

Dr. Büller earned his MD and PhD at the University of Amsterdam. After graduating, he completed his research fellowship in hemostasis and thrombosis in the Departments of Medicine and Clinical Epidemiology and Biostatistics at McMaster University in Hamilton, Ontario, Canada in 1981 – 1982.

Dr. Büller has authored and coauthored more than 554 scientific articles concerning topics in his field (H-index 91). He has been Co-Chairman for the Amsterdam Institute for Cardiovascular Research and is Chairman of the Vascular Medicine Working Group. He is a reviewer for The New England Journal of Medicine, The Lancet, Archives of Internal Medicine, and European Journal of Clinical Investigation, among others. He is a past member of the editorial Board of The Annals of Internal Medicine.

Dr. Büller was Chairman of the chapter Chest Antithrombotic therapy for venous thromboembolic disease of the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, 2004.

Dr. Büller is the recipient of the Established Investigator Award presented by the Dutch Heart Foundation (1993 – 1998) and received the Dutch Society for Vascular Medicine 2005 Award.

Since 2008 he is Honorary Professor of the Royal Netherlands Academy of Arts and Sciences.

Speaking on:

  • Phase III DOAC trials
    • Friday 18th September, 1530